Quidel Corporation, corporate

Quidel Corporation,

05.01.2022 - 15:03:18

The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation

About Quidel Corporation

Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names, Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R), Quidel's comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. Quidel's mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world. For more information about Quidel, visit quidel.com.

*Dr. Embers receives an honorarium for conducting the webinar sponsored by Quidel.

Contact Details

breakwhitelight

JAMES YEAGER

+1 818-264-6812

jim@breakwhitelight.com

Company Website

http://Quidel.com

News Source: News Direct

05.01.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: Quidel Corporation

United States EQS News ID: 1265211 ? End of News DGAP News Service

1265211??05.01.2022?

@ dgap.de